<ѻýҕl>Stem-Cell Transplant Trial Ends in a Drawѻýҕl> Similar PFS with haploidentical bone marrow, double unrelated umbilical cord blood Feb 24, 2020
<ѻýҕl>Rush Limbaugh's Advanced Lung Cancerѻýҕl> Conservative talk show host announces diagnosis Feb 13, 2020
<ѻýҕl>PD-1 vs PD-L1 Inhibitors: Do Outcomes Differ?ѻýҕl> Meta-analysis suggests they aren't equivalent Dec 27, 2019
<ѻýҕl>AHA Dedicates $20 Million to Youth Vaping Researchѻýҕl> Association and partners aim to "hold e-cigarette companies publicly accountable for their lies" Nov 16, 2019
<ѻýҕl>Rheumatoid Arthritis Is No Bar to Cancer Immunotherapyѻýҕl> Small study finds flares common with checkpoint inhibitors, but few patients stopped treatment because of them Nov 13, 2019
<ѻýҕl>Abnormal Shadow on Chest Radiographѻýҕl> Culture findings were key in making the diagnosis Nov 11, 2019
<ѻýҕl>Notable OS Gains with Dual Immunotherapy in Advanced NSCLCѻýҕl> Secondary analysis of CheckMate 227 brings more good news for nivolumab-ipilimumab combo Sep 28, 2019
<ѻýҕl>BCG Vax: A Shot Against Lung Cancer in Native Populations?ѻýҕl> 60-year follow-up data from a vaccine trial found surprising results Sep 25, 2019
<ѻýҕl>Post-Immunotherapy SBRT Boosts Outcomes in Advanced NSCLCѻýҕl> Increased systemic response rate, disease control rate, and PFS in phase II trial Sep 17, 2019
<ѻýҕl>Anti-PD-1/L1 for NSCLC Sparks Talk of the 'C' Wordѻýҕl> Unprecedented survival at 3 and 5 years, but investigators reluctant to say "cure" Sep 10, 2019
<ѻýҕl>'Dirtier' Drugs Step Aside in RET-Positive NSCLCѻýҕl> Over two-thirds of patients respond to selective RET inhibitor Sep 09, 2019
<ѻýҕl>TMB in Lung Cancer: 'Not Ready for Prime Time'ѻýҕl> No association between tumor mutational burden and outcomes in three trials Sep 09, 2019
<ѻýҕl>Peter Fonda’s Lung Cancer Battleѻýҕl> Farewell, Easy Rider: legendary actor dead at 79 Aug 29, 2019
<ѻýҕl>Small Cancer Risk With Lung Micronodulesѻýҕl> Supports classifying small nodules as negative scan result Jul 10, 2019
<ѻýҕl>More Clarity to Steroids' Effect on Anti-PD-1 Therapyѻýҕl> Adverse effects driven by palliative indications associated with poor prognosis Jun 27, 2019
<ѻýҕl>Rheumatologist's Primer on Checkpoint Inhibitorsѻýҕl> Specialist reviews the landscape of cancer drugs' autoimmune side effects Apr 09, 2019
<ѻýҕl>CAR T-Cell Therapy Active in Solid Tumorsѻýҕl> Preliminary data on safety, efficacy in mesothelioma, sarcomas Mar 31, 2019 video
<ѻýҕl>Aggressive Tx in Oligometastatic NSCLC Tied to Improved OSѻýҕl> Histology, intrathoracic disease burden, and bone metastases may predict outcomes Mar 12, 2019
<ѻýҕl>Liquid Biopsy Matches Tissue for NSCLC Guidanceѻýҕl> Increased mutation detection rate, faster turnaround time Feb 27, 2019
<ѻýҕl>Rapid Heart Rate Tied to Higher Mortality in Cancer Patientsѻýҕl> Unexplained tachycardia linked with threefold increase in risk of death Jan 28, 2019
<ѻýҕl>Cancer Treatment and Arthritis: A Growing Complaintѻýҕl> Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
<ѻýҕl>Immunotherapy Combo Flops in Metastatic NSCLCѻýҕl> Durvalumab plus tremelimumab failed to improve survival versus chemotherapy Dec 13, 2018
<ѻýҕl>Highlights from Molecular Targets Symposiuimѻýҕl> Breast cancer gene expression, activity in GI, lung, and limited-mutation tumors Nov 16, 2018
<ѻýҕl>Group of Blood Pressure Drugs Linked to Lung Cancerѻýҕl> 14% higher likelihood in users of ACE inhibitors; causal relationship unproven Oct 25, 2018
<ѻýҕl>Aggressive RT, Surgery Doubles OS in NSCLC With Limited Metsѻýҕl> If new drug produced such a response it would make "millions," said expert Oct 22, 2018 video
<ѻýҕl>FDA Rejects Canakinumab in CVD Preventionѻýҕl> CANTOS data not enough to expand indication Oct 19, 2018
<ѻýҕl>SBRT Doubles 5-Year Survival in Oligometastatic Cancersѻýҕl> Most patients in phase II trial had up to three metastatic lesions Oct 17, 2018
<ѻýҕl>Lung Screening Saves Lives, but Who Should Be Screened?ѻýҕl> Experts debate controversial screening issues in meeting "Smackdown" Oct 11, 2018
<ѻýҕl>Lung Cancer Screening Rates Fall Short in VAѻýҕl> Adherence was 77% among those with negative baseline screens Oct 04, 2018
<ѻýҕl>More Evidence that Screening Cuts Lung Cancer Deathsѻýҕl> Significantly lower risk in men and women Sep 26, 2018
<ѻýҕl>Newer ALK Inhibitor Tops Standard in NSCLCѻýҕl> Significant improvement in PFS with brigatinib after short follow-up Sep 26, 2018
<ѻýҕl>Anti-PD-L1 Drug Boosts Survival in Stage III NSCLCѻýҕl> New standard of care for patients with inoperable disease Sep 26, 2018
<ѻýҕl>Add-On Keytruda Boosts OS in Advanced Squamous Lung Cancerѻýҕl> Benefit seen across all subgroups, PD-L1 expression levels Sep 25, 2018
<ѻýҕl>No Survival Benefit with Cranial RT for NSCLCѻýҕl> Better disease-free survival, fewer brain mets Sep 25, 2018
<ѻýҕl>Nothing Good for Older Lung Cancer Patients From Add-On Cisplatinѻýҕl> Two trials show no survival benefit and more toxicity Jul 26, 2018
<ѻýҕl>Surveillance Not Resection Called Best For Subsolid Lung Nodulesѻýҕl> Opacities tied to increase in lung cancers, but never fatal during a decade of follow-up Jul 25, 2018
<ѻýҕl>Keytruda Alone Bests Chemo in Advanced NSCLCѻýҕl> Monotherapy boosts survival in patients with low PD-L1, no EGFR or ALK alterations Jun 04, 2018
<ѻýҕl>Refusing Lung Cancer Treatment: Class Trumps Raceѻýҕl> Wide variation in groups at highest risk of turning down treatment May 25, 2018
<ѻýҕl>Lung Cancer Screening Rates Disappointѻýҕl> Evidence shows benefit for high-risk smokers but few get tested May 17, 2018
<ѻýҕl>CBT Tops Acupuncture for Treating Insomnia in Cancer Survivorsѻýҕl> But both methods provide alternative to sleeping pills May 17, 2018